Recombinant Human Thrombopoietin in Combination With Rituximab in Immune Thrombocytopenia (ITP)

Clinical trial NCT01506414 · COMPLETED

Trial details

NCT number: NCT01506414
Sponsor: Ming Hou
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Purpura Idiopathic Thrombocytopenic Purpura

Start date: 2009-06-01
Primary completion: 2013-08-01
Enrollment: 91

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.